DermTopic: Acne

Filter Your Results




Topline Results from Novan's SB204 Phase 3 Pivotal Trials: I…

Novan, Inc. (NASDAQ:NOVN) today announced  top-line results from the Company’s two, replicate Pha

DermWireTV: Rhofade Approved, Sun Leaves Acne Behind, Radies…

The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythem…

New Products

PuraCap Introduces Two New Acne Products PuraCap Pharmaceutical, LLC is rolling out two new acne products, Eptex …

Therapeutic Focus: Devices

Growth Predicted in Dermatology Device Market A new report, “Dermatology Devices Market by Diagnostic Device (I…

Recent Developments

Study Assesses Diversity in Dermatologic Clinical Trials Dermatologic clinical trials within the United States reflec…

All About Acne in 2017

Credited as the most common skin disease and a perennial presentation in the dermatology clinic, acne vulgaris continues…

Linda Stein Gold, MD

Color Me Healthy: Patient-Centered Care in Skin of Color

By 2050, more than 50 percent of the US population will have skin of color. As it stands, skin of color patients are the…

Update on Systemic Therapy for Acne

In early 2016, the American Academy of Dermatology published updated guidelines1 for the care of patients with acne vulg…

Joshua Zeichner, MD, Section Editor


Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160

Rick Ehrlich
Associate Publisher
(609) 922-0337

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.